PTC Therapeutics, Inc.
corporate_fare Company Profile
PTC Therapeutics, Inc. (NASDAQ:PTCT) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 27 items for PTCT at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- PTC Therapeutics Reports Positive 24-Month Votoplam Data for Huntington's, Novartis Initiates Phase 3
- PTC Therapeutics Appoints Biotech Banking Veteran Jessica Chutter to Board
- PTC Therapeutics Reports Strong 2025 Financials, Driven by $1.0B Novartis Deal and New Product Launches
- PTC Therapeutics Reports Strong FY2025 Results, Exceeds Revenue Guidance, and Provides Positive 2026 Outlook
- PTC Therapeutics Withdraws Translarna NDA for Duchenne Muscular Dystrophy Following Negative FDA Feedback
Financial Snapshot
Fiscal year ended December 31, 2025
Revenue
$1.73B
Net Income
$682.64M
Diluted EPS
$7.78
Op. Cash Flow
$711.2M
Free Cash Flow
$702.34M
Operating Income
$866.93M
Cash & Equivalents
$984.65M
Debt / Equity
0.00×
Net Margin
39.4%
Shares Outstanding
81.47M sh
Source: 10-K · filed 2026-02-19 · accession 0001104659-26-017575
show_chartPrice Chart
Loading chart...
feed PTCT - Filings & News (Page 2)
PTCT
Apr 28, 2026, 4:29 PM EDT
Price at Filing:
$72.20
Real-time Price:
$56.99
Change:
-$15.21 (-21%)
Market Cap:
$4.714B
PTCT
Mar 25, 2026, 9:00 AM EDT
Price at Filing:
$64.73
Real-time Price:
$56.99
Change:
-$7.74 (-12%)
Market Cap:
$4.714B
PTCT
Feb 19, 2026, 4:36 PM EST
Price at Filing:
$68.00
Real-time Price:
$56.99
Change:
-$11.01 (-16%)
Market Cap:
$4.714B
PTCT
Feb 19, 2026, 4:14 PM EST
Price at Filing:
$68.00
Real-time Price:
$56.99
Change:
-$11.01 (-16%)
Market Cap:
$4.714B
PTCT
Feb 12, 2026, 5:10 PM EST
Price at Filing:
$69.00
Real-time Price:
$56.99
Change:
-$12.01 (-17%)
Market Cap:
$4.714B
PTCT
Jan 12, 2026, 12:00 PM EST
Price at Filing:
$76.07
Real-time Price:
$56.99
Change:
-$19.07 (-25%)
Market Cap:
$4.714B
PTCT
Jan 06, 2026, 4:24 PM EST
Price at Filing:
$78.44
Real-time Price:
$56.99
Change:
-$21.45 (-27%)
Market Cap:
$4.714B